White adipose tissue and cardiovascular disease

Area of Science:

• Endocrinology
• Cardiovascular Science
• Metabolic Research

Background:

• Adipocytes function as endocrine cells, secreting bioactive adipocytokines.
• Key adipocytokines like TNF-alpha, PAI-1, and HBEGF are implicated in vascular disease development.
• Visfatin is linked to obesity-related diseases, while adiponectin shows anti-atherogenic and anti-diabetic properties.

Purpose of the Study:

• To review the role of adipocytokines in cardiovascular disease.
• To discuss the dynamic regulation of adipocytokine secretion by nutritional status.
• To highlight the impact of visceral fat accumulation on adipocyte function and disease.

Main Methods:

• This is a review article, synthesizing existing research on adipocytokines.
• Literature search and analysis of studies on adipocytokines and cardiovascular disease.
• Discussion of the mechanisms linking adipocyte dysfunction to metabolic and circulatory diseases.

Main Results:

• Adipocytokines play a crucial role in the development of cardiovascular diseases.
• Visceral fat accumulation leads to adipocyte dysfunction, characterized by altered secretion of specific adipocytokines.
• Adiponectin emerges as a protective factor against atherosclerosis and diabetes.

Conclusions:

• Adipocytokines are critical mediators in the pathogenesis of cardiovascular diseases.
• Understanding adipocytokine profiles is essential for managing obesity-related metabolic and circulatory disorders.
• Targeting adipocytokines may offer therapeutic strategies for cardiovascular disease prevention and treatment.